Home » Business News » 2012 » June » June 9

Business News on June 9, 2012

Call to iFans to wear 'black turtlenecks' to honor Steve Jobs next week
Makers of new Apple app, ChallengeLoop, in an attempt to draw eyes during their annual developers conference next week, has issued a challenge to iFans all around the globe, prompting them to wear the iconic black turtleneck like Steve Jobs, to pay tribute to the legendary Apple Inc. co-founder. ANI

Two-wheeler sales grow in Tripura
Economic activities in Tripura and the rising per capita income has resulted in enhanced sale of two wheelers in the state. ANI

Swiss bank may have lost $350mln due to Facebook IPO glitches
Swiss bank UBS may have lost as much as 350 million dollars due Nasdaq stock exchange's technical glitches that marred Facebook's Initial Public Offering (IPO) on May 18. ANI

Swiss court rules 'Google need not blur faces, car plates on Street View service'
Switzerland's highest court has ruled that the Internet search giant Google does not have to blur all faces and license plates appearing on its popular Street View application in the country. ANI

Microsoft's Bing partners with Encyclopaedia Britannica for expanded search results
Microsoft search engine Bing has signed a deal with Encyclopaedia Britannica to bring richer content to its search results. ANI

Govt. to pass Pension Bill after consulting TMC: Mukherjee
Finance Minister Pranab Mukherjee has said the government will pass the Pension Bill after consulting its key ally Trinamool Congress. ANI

VentriPoint Multi-Centre Clinical Trial Focuses on Ultrasound Diagnostic Tool for Heart Analysis
VentriPoint Diagnostics Ltd. (TSX VENTURE: VPT)(OTCQX: VPTDF) is pleased to announce that Mayo Clinic has joined its multi-centre clinical trial to evaluate the use of an ultrasound diagnostic tool (the VMS™ heart analysis system) for patients with pulmonary arterial hypertension (PAH). Robert Frantz, M.D MarketWire

Lyxumia(R) (lixisenatide) in Combination With Basal Insulin Plus Oral Anti-Diabetics Significantly Reduced HbA1c and Post-Prandial Glucose

Lantus(R) Initiation After Metformin Achieved Superior Glycemic Control Versus Sitagliptin in Type 2 Diabetes
Sanofi (EURONEXT: SAN) (NYSE: SNY) announced today that people with early type 2 diabetes uncontrolled on metformin demonstrated superior HbA1c -- glycated hemoglobin -- reduction with Lantus® (insulin glargine [rDNA origin] injection) versus sitagliptin MarketWire

Comment on this story